baber/WOPTO huggingface dataset:
Patent NZ-246768-A (NZ)
Title: 3-azabicyclo[3.1.0]hexane intermediates useful in the preparation of quinoline antibiotics
Inventor: BRAISH TAMIM F
IPC: C07D209/52
Filed: 1993-01-07
Abstract: This invention relates to compounds of the formulae  (* CHEMICAL STRUCTURE *) (III) and  (* CHEMICAL STRUCTURE *) (IV) wherein R and X are defined as below. These compounds are useful as intermediates in the syntheses of azabicyclo quinoline carboxylic acids having antibacterial activity.
Patent NZ-264439-A (NZ)
Title: A safety syringe comprises a cartridge needle unit having a retractable needle within the cartridge with details regarding means for releasing needle from hub
Inventor: JOHNSON KEVIN M
IPC: A61M5/178
Filed: 1994-09-12
Abstract: This invention relates to a novel cartridge-needle unit having a retractable needle for use with disposable or reusable holders to form safety syringes.The cartridge-needle unit comprises a cartridge (10) comprising a hollow body (14), a septum (18) at the distal end of the body (14), means (16) for retaining the septum (18), and a plunger (20), axially and reciprocally slidable through the interior of the body (14); a needle (22) capable of being retracted within the cartridge (10); a hub (24) comprising a sleeve (26) adapted to be snapped on the distal end of the cartridge (10); means (28,30,32) for retaining the needle (22) within the hub (24) during an injection; and means (28,30) for releasing the needle (22) from the hub (24) after the injection comprising an element (30) attached to the needle (22), and having a diameter greater than said needle, capable of passing through the septum (18).The retractable cartridge-needle unit exhibits improved reliability, reduces the tendency for body fluids and/or medication to remain in an unprotected area upon retraction of the needle and virtually eliminates the possibility that the needle can be released into the patient.
Patent NZ-324509-A (NZ)
Title: Extraction of proteins into carbon dioxide
Inventor: BECKMAN ERIC J
IPC: C07K1/14
Filed: 1996-11-13
Abstract: here is provided a process for the extraction of water soluble biomaterials such as enzymes or proteins into carbon dioxide utilizing certain carbon dioxide-soluble surfactants. Also provided are certain carbon dioxide-soluble surfactants useful in the extraction of proteins.
Patent NZ-334169-A (NZ)
Title: Method and device for measuring the volumetric flow of a fluid
Inventor: KOPL MANFRED
IPC: B67D7/20
Filed: 1997-08-23
Abstract: According to a method of measuring the volumetric flow of a fluid, a volume-measuring device 1 comprising a movable element, for example two or more screw spindles, emits measurement signals M derived from the cyclical movement of the element to a measuring transducer 2 which forms counting signals from the measurement signals.  In order to improve measuring accuracy, the cycle frequency of the movable element is determined from the measurement signals, and stored correction factors for the respective cycle frequency are used to form and emit counting signals proportional to the actual volumetric flow.  Each measurement signal is assigned a weighted volume value by the correction factor and such volume values are totaled up by transducer 2, which generates a counter signal when the sum total has reached the level of a standard volume level or multiple thereof.
Patent NZ-336514-A (NZ)
Title: Method of PCR testing of pooled blood samples
Inventor: PEDDADA LORRAINE B
IPC: B01L3/00
Filed: 1998-01-06
Abstract: A method for uniquely identifying viral positive biological fluid donations in the fewest number of high-sensitivity test cycles.  The method comprises: 1) providing a multiplicity of biological fluid donations, 2) defining an n-dimensional matrix, where n is an integer, and the matrix further comprises a multiplicity of elements.  Each element is defined by an intersection of the n-dimensions of the matrix and each individual element is identified by a respective matrix notation 3) taking a sample from each of the biological fluid donations 4) mapping each sample to a respective particular one of each element of the matrix, each individual sample being identified by its corresponding element's respective matrix notation 5) taking aliquots from each sample, the number of aliquots taken from each sample defined by the number of dimensions characterizing the matrix 6) forming subpools from the aliquots of each sample, each subpool containing an aliquot from all samples identified by a matrix notation in which one dimensional index is fixed, 7) Providing the subpools to a high-sensitivity testing facility, wherein all of the subpools are tested for a viral indication in a single high-sensitivity test cycle. 8) Determining the respective fixed dimensional indices of subpools which return a positive viral indication, and 9) Combining said fixed dimensional indices into a matrix notation, thereby unambiguously identifying a unique matrix element defined by the matrix notation, thus unambiguously identifying a uniquely viral positive sample.
Patent NZ-502878-A (NZ)
Title: Compressed nitroglycerin tablet containing glyceryl monstearate as a stabilizer
Inventor: CAPELLA ROBERTO L
IPC: A61K31/21
Filed: 1998-09-16
Abstract: A stable composition comprises effective amounts of nitroglycerin, lactose, silica, starch, glyceryl monostearate and lubricant wherein the nitroglycerin is the sole pharmacologically agent.
Patent NZ-503857-A (NZ)
Title: Carbon dioxide assisted hydrolysis of aminophosphonates
Inventor: JOHNSON TODD J
IPC: C07F9/38
Filed: 1998-10-15
Abstract: A process for producing an aminophosphonic acid, comprising: (a) Contacting in an aqueous medium, an aminophosphonate ester with a base, (b) adding a hydrolysis facilitator selected from the group consisting of CO2, CS2 and COS, (c) hydrolysing the aqueous medium comprising the aminophosphonate ester, base and hydrolysis facilitator at a temperature above 50°C. The process preferably produces an aminophosphonic acid of formula (I), wherein n is 1 to 3, and R is hydrogen, an alkyl group containing 1 to 6 carbon atoms, an aryl group containing 6 to 12 carbon atoms, a carboxylate salt or ester, or hydroxyethyl.
Patent NZ-504413-A (NZ)
Title: Device for assisting a surgeon position surgical instruments with first axis parallel to plane of patient
Inventor: ANDRE JACQUES
IPC: A61B90/50
Filed: 1998-11-16
Abstract: A device for positioning a surgical instrument, characterized in that it comprises a fixed support (1) combined with at least: a first mobile element (4) articulated on the fixed support (1) about a first axis (H1) substantially parallel to the plane wherein the patient is placed (PP') and capable of carrying out a first movement; a second mobile element (5) articulated at the end of the first element (4) about a second axis (H2) substantially parallel to the plane wherein the patient is placed (PP') and capable of carrying out a second movement; a deformable element (6) fixed on one side to the end of the second mobile element (5) and capable of carrying out a third rotating movement about a third axis (C); a prehensile member (7) fixed on the side opposite to that of the second element to the deformable element; a device (8) for locking a surgical instrument (9) on the prehensile member(7); and actuating means (10 and 11) for producing the rotating movements about the different axes (H1, H2 and C).
Patent NZ-505338-A (NZ)
Title: Ultra-high strength ausaged steels with excellent cryogenic temperature toughness and having a micro-laminate microstructure of austenite film layers and laths of martensite and bainite
Inventor: KOO JAYOUNG
IPC: C21D8/02
Filed: 1998-06-18
Abstract: An ultra-high strength, weldable, low alloy steel with excellent cryogenic temperature toughness in the base plate and in the heat affected zone (HAZ) when welded, having a tensile strength greater than 830 MPa (120 ksi) and a micro-laminate microstructure comprising austenite film layers and fine-grained martensite/lower bainite laths, is prepared by heating a steel slab.  The steel slab comprising iron and specified weight percentages of some or all of the additives carbon, manganese, nickel, nitrogen, copper, chromium, molybdenum, silicon, niobium, vanadium, titanium, aluminum, and boron.  The slab is then reduced to form a plate in one or more passes in a temperature range in which austenite recrystallizes.  The plate is then finish rolled in one or more passes in a temperature range below the austenite recrystallization temperature and above the Ar3 transformation temperature.  Quenching the finish rolled plate to a Quench Stop Temperature (QST).  The quenching is stopped and for a period of time, either by holding the plate substantially isothermally at the QST or slow-cooling the plate before air cooling, or simply air cooling the plate to ambient temperature.
Patent NZ-508103-A (NZ)
Title: Photoinhibitory promoter
Inventor: SASAKI YUKIKO
IPC: C07K14/415
Filed: 2000-03-03
Abstract: A DNA fragment or promoter for expressing a gene of interest light-repressibly or specifically in the dark is disclosed. A light-repressible promoter was obtained from the 5' upstream region of a plant gene expressed light-repressibly or specifically in the dark, and the function of said promoter was extensively analysed to reveal a cis-element sequence and a core sequence involved in light-repressible expression. An expression cassette comprising a DNA fragment carrying each of these sequences upstream of a gene of interest can be constructed and transfected into a plant cell or a plant to provide a plant cell or a plant that expresses the gene of interest light-repressibly or specifically in the dark.
Patent NZ-508674-A (NZ)
Title: A method for determining patient-specific dosimetry of a radippharmaceutical
Inventor: SIEGEL JEFFRY A
IPC: A61K51/00
Filed: 1999-06-04
Abstract: A patient-specific optimally effective radiation  dose for administration of a radiopharmaceutical to a patient for treatment  of  a disease may be established  by  basing  the calculation  of  the  appropriate therapeutic  dose  on  the desired  total  body dose, the maximum tolerated  dose,  the typical  clearance  profile of the radiopharmaceutical,  the patient's  mass or maximum effective mass, and the  patient- specific  residence  time of the radiopharmaceutical  or  an analog  in  the whole body of the patient.  The use  of  the method allows for treatment of a patient with an appropriate dose,  which is maximally effective against the disease  yet minimally  toxic.  The determination of  a  patient-specific therapeutic  dose may be assisted by the use of  a  software program   set   to   the  particular   parameters   of   the radiopharmaceutical.
Patent NZ-512083-A (NZ)
Title: Methods of increasing lean tissue mass using OB protein compositions
Inventor: PELLEYMOUNTER MARY ANN
IPC: A61K38/17
Filed: 1996-11-04
Abstract: A fusion protein optionally having a N-terminal methionine, comprising an antibody constant region or portion thereof attached to the N-terminus of a human OB protein. These fusion proteins are useful for treating obesity or increasing insulin sensitivity.
Patent NZ-515480-A (NZ)
Title: Treatment of a composition comprising a trimetlylohalkane bis-monolinear formal
Inventor: SLINKARD WILLIAM E
IPC: C07C31/22
Filed: 2000-05-26
Abstract: A process for treating a composition containing a substantial proportion of trimethylolpropane bis-monolinear formal (TMP-BMLF) or trimethylolethane bis-monolinear formal (TME-BMLF), e.g., a heavy ends residue obtained from the purification of a crude trimethylolpropane (TMP) or trimethylolethane (TME) product, wherein the composition is contacted at an elevated temperature with a strong acid catalyst, e.g., methanesulfonic acid, to produce a composition containing significantly increased amounts of TMP and trimethylolpropane monocyclic formal (TMP-MCF) or TME and trimethylolethane monocyclic formal (TME-MCF) respectively.
Patent NZ-517591-A (NZ)
Title: Acrylic block copolymer pigment dispersants containing heterocyclic groups
Inventor: HUYBRECHTS JOSEF
IPC: C09D11/00
Filed: 2000-10-04
Abstract: A composition suitable for use as a pigment dispersant comprising an acrylic block copolymer, which has: - a relatively polar A segment, which contains a heterocyclic group selected from the group consisting of mononuclear and/or dinuclear 5 and/or 6 membered rings containing at least one nitrogen atom not connected to a hydrogen atom, and - a relatively non-polar B segment.
Patent NZ-519746-A (NZ)
Title: Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals
Inventor: PAGE Clive
IPC: C07D295/13
Filed: 2000-12-15
Abstract: Use of certain quaternary ammonium compounds of following formula (I): Y- J- E An- as active ingredient in the manufacture of a medicament for use in the treatment and/or prevention of cough in warm-blooded animals, including humans is disclosed, wherein J is independently selected from a group represented by one of formulae (II), (III) and (IV); Y, E and An- are as defined in the specification.
Patent NZ-523716-A (NZ)
Title: Medical valve with positive flow characteristics
Inventor: FANGROW THOMAS F
IPC: A61M39/26
Filed: 2001-07-11
Abstract: A valve for selectively permitting a fluid flow between first and second medical implements is disclosed. The valve has a housing with an interface suitable for receiving a connector portion of a first medical device such as a catheter, and a seal made of a flexible material. The seal has a first end in fluid communication with the interface, a second end suitable for receiving the second medical device, and at least one slit in fluid communication with the first end and the second end. The slit defines a restricted fluid flow path and a relatively small interior volume when in an undisturbed state, defines an expanded fluid flow path and a larger interior volume upon the introduction of the second medical instrument into the slit, and retracts to define a restricted flow path and a small interior volume upon the withdrawal of the second medical device from the seal.
Patent NZ-526469-A (NZ)
Title: Pyrazole compounds useful as protein kinase inhibitors
Inventor: BEBBINGTON DAVID
IPC: A61K31/541
Filed: 2001-12-19
Abstract: This invention describes novel pyrazole compound of formula IIc.. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
Patent NZ-527396-A (NZ)
Title: Antibodies and fragments thereof for the binding of IL-22 and use therefore for treating inflammatory disorders
Inventor: JACOBS KENNETH
IPC: A61P9/10
Filed: 2002-02-25
Abstract: Disclosed are antibodies and antigen binding fragments which specifically bind IL-22, wherein the antibodies inhibit STAT-3 phosphorylation that is mediated by IL-22. These antibodies and fragments there of are also disclosed to be used in the preparation of a medicament for the amelioration of symptoms associated with arthritis.
Patent NZ-537208-A (NZ)
Title: Differentiation modulating agents and uses therefor
Inventor: PRINS JOHANNES BERNHARD
IPC: A61P35/00
Filed: 2003-06-27
Abstract: Disclosed is the use of an agent in the manufacture of a medicament for treating or preventing obesity or conditions of localised increases in adipogenesis, wherein the agent antagonises a FGF signalling pathway selected from the FGF-I signalling pathway and the FGF-2 signalling pathway to inhibit or otherwise decrease adipogenesis, and wherein the agent is selected from the group consisting of: antibodies; antigen-binding molecules; inhibitor peptide fragments; sense and antisense molecules; ribozymes; ds RNA molecules; RNAi molecules; co-suppression molecules; phospholipase C inhibitors; and kinase inhibitors.
Patent NZ-540322-A (NZ)
Title: An advertisement print and a method of generating an advertisement print with print being a perspective projection of a three-dimensional element to an inclined plane
Inventor: SONDERGAARD CHRISTIAN
IPC: G09F19/22
Filed: 2003-11-06
Abstract: The disclosure relates to a method of generating an advertisement print comprising advertisement information, where the advertisement print is adapted for being positioned on a surface of a substantially plane print carrier, where the substantially plane print carrier has a predefined surface area. The method comprises the step of projecting the predefined surface area to a plane perpendicular to a line of sight between a predefined viewpoint and the print carrier, placing the advertisement information within boundaries of the projected predefined surface area and generating the advertisement print by graphically transforming the projected predefined surface area together with the advertisement information to an area similar to the predefined surface area of the substantially plane print carrier. The disclosure further relates to an advertisement print being printed on a substantially plane print carrier. The print is optimised to be placed on a surface of an inclined plane having a first inclination, and the print comprises a first element being a perspective projection of a first three-dimensional element to the inclined plane. The projection is optimised to a predefined viewpoint, where a supporting surface of the three-dimensional element is parallel to a supporting plane having a second inclination being different from the first inclination.
Patent NZ-541514-A (NZ)
Title: A food preparation and distribution tray
Inventor: HAMBLIN RONALD GEOFFREY
IPC: B65D71/62
Filed: 2004-01-30
Abstract: A food preparation and distribution tray adapted to receive and support cups, such as paper "patty" cups, used for preparing food products such as muffins. The tray has a plurality of openings (13) for each individual cup, with each cup supported at two or more places by upper wall (3) and the lower wall. The support means may suspend the cups above a base of the tray, or alternatively, the tray may be formed so that the cups rest on the tray's lower wall and are supported by only upper wall (3). The muffins may be baked in the cups supported by the tray. The tray may be formed from a carton board blank that has been cut, folded and glued to form a sleeve that includes folded end walls and internal supports.
Patent NZ-543670-A (NZ)
Title: Benzimidazole-derivatives as factor Xa inhibitors
Inventor: NAZARE MARC
IPC: A61P7/02
Filed: 2004-05-05
Abstract: Disclosed are compounds of the formula (I), wherein the substituents have the meanings indicated in the claims. The compounds exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. Also disclosed are processes for the preparation of compounds of the formula (I), their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
Patent NZ-544843-A (NZ)
Title: Electromechanical lock cylinder
Inventor: KRISCH VOLKER
IPC: E05B47/06
Filed: 2004-06-22
Abstract: An electromechanical lock cylinder is disclosed. The lock cylinder, which interacts with evaluating electronics for recognizing an access authorization and comprises a housing that has two opposing cylindrical cavities (12). A lock core, which can be actuated by a key, or a knob shaft (11), which is joined to a knob in a rotationally fixed manner, is rotationally mounted in the cavities. The lock core and/or knob shaft (11) interact with a lock lug (13), which actuates, in particular, a bolt or latch of a door lock. When the key fits or in the event of a successful access authorization, an electromechanically driven blocking or coupling element (14) is moved out of the position of rest and into an angular position, and a rotationally fixed joining between the key or knob and the lock lug (13) is effected. The invention is characterized in that, when the blocking or coupling element (14) is in a position of rest, the lock lug (13) can be freely rotated relative to both lock cores or to both knob shafts (11).
Patent NZ-545950-A (NZ)
Title: Elevator with vertical vibration compensation
Inventor: HUSMANN JOSEF
Filed: 2006-03-14
Abstract: Apparatus for deducing transitory vertical vibration acting on an elevator car is disclosed. The elevator car travels along guide rails 6 within a hoistway and has a main drive to propel the car. A sensor 30 s mounted on the car to measure a vertical travel parameter, such as velocity or acceleration, of the car and a comparator 32 compares the sensed parameter with a reference value derived from the main drive. An auxiliary motor 24 is mounted on the car to exert a vertical force on at least one of the guide rails in response to an error signal output from the comparator.
Patent NZ-549928-A (NZ)
Title: Process for producing cheese
Inventor: FATUM TINE MUXOLI
IPC: A23C19/032
Filed: 2005-03-22
Abstract: Disclosed is a process for increasing cheese yield comprising adding to cheese milk, or a fraction of cheese milk, a phospholipase selected from the group consisting of phospholipase C, phospholipase D, and combinations thereof; and producing cheese from the cheese milk.
Patent NZ-552132-A (NZ)
Title: Acidic milk drink
Inventor: NAKANO MASATOSHI
IPC: A23C9/13
Filed: 2005-05-24
Abstract: Disclosed is an acidic milk drink with a favourable flavour which has excellent quality, stability and a light texture required for low calorie drinks even at a low milk solid non-fat content in the acidic milk drink. Namely, an acidic milk drink characterized by containing polydextrose and sucrose at a solid non-fat milk content of 1.0 to 4.0% by mass.
Patent NZ-553374-A (NZ)
Title: Food additive comprising enzyme hydrolysates of yeast
Inventor: AUCLAIR ERIC
IPC: A23K1/16
Filed: 2005-08-17
Abstract: Disclosed is the use of enzymatic hydrolysates of yeast containing 5'-nucleotides and/or peptides of at least 1000 daltons for producing a preparation for the prevention and/or treatment of cannibalism in livestock.
Patent NZ-553685-A (NZ)
Title: Apparatus for sorting postal items
Inventor: WILCOCK PETER JOHN
Filed: 2006-03-07
Abstract: An apparatus for sorting postal items is disclosed. The apparatus comprises at least two groups of sorting compartments 109a, 109b and a translation mechanism, wherein a first and second group of sorting compartments move relative to each other and translate, using the translation mechanism, between a first and second working configuration.
Patent NZ-553813-A (NZ)
Title: Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
Inventor: CHOI YONG MOON
IPC: A61K31/27
Filed: 2005-09-15
Abstract: Disclosed is the use of a compound or a pharmaceutically acceptable salt or ester thereof of formula (I) or formula (II) in the preparation of a medicament for treating, preventing, reversing or inhibiting epileptogenesis in a human subject who is at risk of developing epilepsy or a seizure-related disorder but does not have epilepsy or clinical evidence of seizures.
Patent NZ-555173-A (NZ)
Title: Process for producing desflurane from isoflurane with antimony pentafluoride and HF
Inventor: TERRELL ROSS C
IPC: C07C41/22
Filed: 2005-11-17
Abstract: Disclosed is a process for the preparation of desflurane, said process comprising forming a mixture comprising 1-chloro-2,2,2- trifluoroethyl difluoromethyl ether (CF3CHCIOCHF2, isoflurane), hydrogen fluoride and antimony pentafluoride, such that desflurane is formed. Also disclosed is a process for the preparation of desflurane which comprises: a) forming a mixture comprising CF3CHCIOCHF2, antimony pentafluoride, and hydrogen fluoride; and b) adding hydrogen fluoride to the mixture at a rate approximately equal to or less than the rate at which the hydrogen fluoride reacts with the CF3CHCIOCHF2 to form desflurane.